AVSR yields 1000000.00% · PFE yields 6.13%● Live data
📍 AVSR pulled ahead of the other in Year 1
Combined, AVSR + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AVSR + PFE for your $10,000?
Avistar Communications Corporation designs, develops, manufactures, markets, and sells networked video communications products primarily in the United States, western Europe, and Asia. It delivers a suite of video, audio, and collaboration solutions that are designed to support users in the office through the conference room or on-the-go. The company offers Avistar C3, a communication and collaboration platform, which provides an integrated suite of video, audio, and collaboration applications that include on-demand access to interactive video calling and conferencing, content creation and publishing, broadcast origination and video distribution, and video-on-demand, as well as data sharing, presence-based directory services, and network management. Avistar Communications Corporation also provides various services for the implementation and support of its video communications products; and offers software development, maintenance, support, and training services. In addition, it is involved in the development, prosecution, maintenance, support, and licensing of the intellectual property and technology used in the company's video communications systems. Further, the company sells and licenses a set of desktop products and infrastructure products that combine to form an Avistar video-enabled visual communication and collaboration solution. Avistar Communications Corporation offers its products and services through its direct sales force, as well as through strategic partners and value added resellers. The company was formerly known as Avistar Systems Corporation and changed its name to Avistar Communications Corporation in April 2000. Avistar Communications Corporation was founded in 1993 and is headquartered in San Mateo, California.
Full AVSR Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.